BIO-RAD LABORATORIES, INC. (BIO)

320.09 -1.41 (-0.44%)

As of 2025-12-01 22:05:01 EST

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.

Traded asNYSE: BIO
ISINUS0905722072
CIK0000012208
LEI549300ZC1GPV35XYDK53
EIN941381833
Sector—
IndustryLaboratory Analytical Instruments
CEONorman Schwartz
Employees7,700
Fiscal Year End1231
Address1000 ALFRED NOBEL DRIVE, HERCULES, CA, 94547
Phone5107247000
Websitehttp://bio-rad.com
Stock Quotes
trading_symbolregistrant_nametimepricechangepercentage_change
BIOBIO-RAD LABORATORIES, INC.2025-12-01 22:05:01320.09-1.41-0.44
This is a preview of the latest data. Subscribe to access the full data.
Company Information
trading_symbolcentral_index_keyregistrant_nameisin_numberlei_numberein_numberexchangesic_codesic_descriptionfiscal_year_endstate_of_incorporationaddress_streetaddress_cityaddress_stateaddress_zip_codeaddress_countryaddress_country_codephone_numbermailing_addressbusiness_addressformer_nameindustryfounding_datechief_executive_officernumber_of_employeeswebsitemarket_capshares_issuedshares_outstandingdescriptionupdate_time
BIO0000012208BIO-RAD LABORATORIES, INC.US0905722072549300ZC1GPV35XYDK53941381833NYSE3826Laboratory Analytical Instruments1231DE1000 ALFRED NOBEL DRIVEHERCULESCA94547UNITED STATESUS51072470001000 ALFRED NOBEL DRIVE, HERCULES, CA, 945471000 ALFRED NOBEL DRIVE, HERCULES, CA, 94547BIO RAD LABORATORIES INC—1952Norman Schwartz7,700http://bio-rad.com6,181,361,340—27,668,031Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The company was founded in 1952 in Berkeley, California, by husband and wife team David and Alice Schwartz, both graduates of the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has operations worldwide.2025-11-27 15:35:25
This is a preview of the latest data. Subscribe to access the full data.
BIO Stock Price (End-of-Day)
This is a preview of the latest data. Subscribe to access the full data.
BIO Stock Price (1-Minute)
This is a preview of the latest data. Subscribe to access the full data.
Market Cap
Fiscal YearMarket CapChange In Market CapPercentage Change In Market CapShares OutstandingChange In Shares OutstandingPercentage Change In Shares Outstanding
20186,181,361,3401,386,069,91028.9048———
20174,795,291,4301,793,401,50959.7424———
20163,001,889,921-124,254,828-3.9747———
This is a preview of the latest data. Subscribe to access the full data.
Executive Compensation
Executive NameExecutive PositionFiscal YearSalaryBonusStock AwardsIncentive Plan CompensationOther CompensationTotal Compensation
Andrew J. LastChief Operating Officer, Executive Vice President2023660,25002,587,795022,0443,270,089
Dara Grantham WrightPresident, Executive Vice President2023562,39001,552,976017,7602,133,126
Norman SchwartzChief Executive Officer, Chairman, President20231,040,00006,211,5370212,3417,463,878
Ilan DaskalChief Financial Officer, Executive Vice President2023565,09302,070,766020,1122,655,971
Simon MayPresident, Executive Vice President2023517,81301,552,976018,4322,089,221
This is a preview of the latest data. Subscribe to access the full data.
Employee Count
Fiscal YearEmployee Count
20247,700
20238,030
20228,200
This is a preview of the latest data. Subscribe to access the full data.
Income Statements
Fiscal Year202420232022
Revenue2,566,500,0002,671,262,0002,802,249,000
Cost Of Revenue1,187,600,0001,244,316,0001,234,919,000
Gross Profit1,378,900,0001,426,946,0001,567,330,000
Research And Development Expenses295,900,000247,427,000256,889,000
General And Administrative Expenses814,000,000841,723,000827,825,000
Operating Expenses———
Operating Income269,000,000337,796,000482,616,000
Net Income-1,844,200,000-637,324,000-3,627,535,000
Earnings Per Share Basic-65.36-21.82-121.79
Earnings Per Share Diluted-25.57-21.82-121.79
Weighted Average Shares Outstanding Basic28,214,00029,209,00029,785,000
Weighted Average Shares Outstanding Diluted28,214,00029,209,00029,785,000
This is a preview of the latest data. Subscribe to access the full data.
Balance Sheet Statements
Fiscal Year202420232022
Cash And Cash Equivalents488,100,000403,815,000434,215,000
Marketable Securities Current1,176,400,0001,203,327,0001,356,457,000
Accounts Receivable452,500,000489,017,000494,645,000
Inventories760,000,000780,517,000719,316,000
Non Trade Receivables———
Other Assets Current30,700,00026,054,00023,604,000
Total Assets Current3,030,300,0003,048,330,0003,157,976,000
Marketable Securities Non Current4,839,200,0007,698,070,0008,830,892,000
Property Plant And Equipment528,100,000529,007,000498,612,000
Other Assets Non Current101,900,00094,850,00094,599,000
Total Assets Non Current743,900,000776,100,000728,800,000
Total Assets9,364,100,00012,299,070,00013,501,666,000
Accounts Payable122,300,000144,625,000135,041,000
Deferred Revenue47,800,00051,100,00052,211,000
Short Term Debt1,200,000500,000500,000
Other Liabilities Current147,200,000161,621,000117,437,000
Total Liabilities Current467,800,000522,799,000568,708,000
Long Term Debt1,210,400,0001,210,100,0001,197,716,000
Other Liabilities Non Current177,200,000195,113,000195,912,000
Total Liabilities Non Current2,327,000,0003,035,138,0003,317,706,000
Total Liabilities2,794,800,0003,557,937,0003,886,414,000
Common Stock02,0002,000
Retained Earnings7,416,400,0009,260,629,0009,898,203,000
Accumulated Other Comprehensive Income-538,200,000-336,038,000-466,822,000
Total Shareholders Equity6,569,300,0008,741,133,0009,615,252,000
This is a preview of the latest data. Subscribe to access the full data.
Cash Flow Statements
Fiscal Year202420232022
Depreciation And Amortization151,600,000145,900,000137,300,000
Share Based Compensation Expense62,300,00061,300,00060,900,000
Other Non Cash Income Expense—011,900,000
Change In Accounts Receivable-16,200,000-11,400,00087,400,000
Change In Inventories-8,500,00046,300,000158,800,000
Change In Non Trade Receivables———
Change In Other Assets———
Change In Accounts Payable———
Change In Other Liabilities-9,100,000-600,000-20,300,000
Cash From Operating Activities455,200,000374,943,000194,447,000
Purchases Of Marketable Securities1,276,600,000689,041,0002,060,238,000
Sales Of Marketable Securities1,106,000,000501,939,000708,214,000
Acquisition Of Property Plant And Equipment165,600,000156,680,000112,782,000
Acquisition Of Business———
Other Investing Activities001,375,000
Cash From Investing Activities-160,200,00020,208,000-1,207,593,000
Tax Withholding For Share Based Compensation3,400,00014,936,00013,967,000
Payments Of Dividends———
Issuance Of Common Stock——-3,373,000
Repurchase Of Common Stock203,600,000650,000,000215,679,000
Issuance Of Long Term Debt———
Repayment Of Long Term Debt400,000467,000510,000
Other Financing Activities19,200,00018,484,00017,560,000
Cash From Financing Activities-218,800,000-425,647,000973,576,000
Change In Cash85,400,000-30,175,000-36,589,000
Cash At End Of Period488,100,000403,815,000434,215,000
Income Taxes Paid99,400,000129,593,000158,259,000
Interest Paid46,500,00047,489,00024,435,000
This is a preview of the latest data. Subscribe to access the full data.
Key Metrics
Fiscal Year202420232022
Earnings Per Share-65.36-21.82-121.79
Price To Earnings Ratio-5.0262-14.7979-3.4526
Earnings Growth Rate199.5417-82.0839-185.5687
Price Earnings To Growth Ratio-0.02520.18030.0186
Book Value Per Share232.8383299.2616322.822
Price To Book Ratio1.41091.0791.3025
Ebitda-1,544,300,000-312,392,000-3,293,862,000
Enterprise Value9,992,081,14010,238,079,01013,288,295,650
Dividend Yield———
Dividend Payout Ratio———
Debt To Equity Ratio0.18440.13850.1246
Capital Expenditures150,693,000176,295,000144,960,000
Free Cash Flow304,507,000198,648,00049,487,000
Return On Equity-0.2807-0.0729-0.3773
One Year Beta0.73320.84791.0933
Three Year Beta0.98030.97660.8473
Five Year Beta0.83650.87010.8854
This is a preview of the latest data. Subscribe to access the full data.
Insider Transactions
Insider NameRelationship To IssuerTransaction DateAmount Of SecuritiesAcquired Or DisposedSecurities Owned Following Transaction
BARRY JAMESEVP, President, LSG2025-11-06699D509
DiVincenzo Jonathan P.President & COO2025-10-241,869A1,869
DiVincenzo Jonathan P.President & COO2025-10-24950D919
DiVincenzo Jonathan P.President & COO2025-10-241,869D5,609
EVRAN SEDATEVP, Global Supply Chain2025-10-201,044A2,567
This is a preview of the latest data. Subscribe to access the full data.
Senate Trading
Name Of Reporting PersonType Of Reporting PersonReport DateTransaction TypeTransaction DateOwner TypeAmount
Thomas H TubervilleSenator2022-04-08Sale (Full)2022-03-30Joint$1,001 - $15,000
Thomas H TubervilleSenator2021-07-23Purchase2021-03-29Joint$1,001 - $15,000
Thomas R TillisSenator2015-02-26Sale (Full)2015-02-13Joint$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
House Trading
Name Of Reporting PersonReport DateStateTransaction TypeTransaction DateOwner TypeAmount
Lois Frankel2023-10-10FL22Sale2023-09-08—$1,001 - $15,000
Lois Frankel2023-07-28FL22Purchase2023-06-29—$1,001 - $15,000
Lois Frankel2023-07-28FL22Purchase2023-06-28—$1,001 - $15,000
Susie Lee2022-12-29NV03Sale2022-11-30Joint$1,001 - $15,000
Susie Lee2021-02-10NV03Sale (Partial)2021-01-05Joint$1,001 - $15,000
This is a preview of the latest data. Subscribe to access the full data.
Institutional Holdings
Investor NamePeriod Of ReportMarket ValueAmount Of SecuritiesPrice Per Security
Strategic Advocates LLC2025-09-301,1224280.5
JPMORGAN CHASE & CO2025-09-3015,771,93856,250280.39
CIBC Private Wealth Group LLC2025-09-3092,809331280.3897
Bell Investment Advisors, Inc2025-09-301,9637280.4286
CAPTRUST FINANCIAL ADVISORS2025-09-30244,500872280.3899
This is a preview of the latest data. Subscribe to access the full data.
Mutual Fund Holdings
Registrant NamePeriod Of ReportFund NameFund SymbolAmount Of UnitsValue In UsdPercentage Value Compared To Assets
PRAXIS FUNDS2025-09-30Praxis Small Cap Index Fund Class IMMSIX540151,410.60.076
PRAXIS FUNDS2025-09-30Praxis Small Cap Index Fund Class AMMSCX540151,410.60.076
RYDEX SERIES FUNDS2025-09-30Class CRYDCX5314,860.670.1221
RYDEX SERIES FUNDS2025-09-30Class ARYAHX5314,860.670.1221
RYDEX SERIES FUNDS2025-09-30Class HRYMDX5314,860.670.1221
This is a preview of the latest data. Subscribe to access the full data.